Skip to main content
Duke 100 Centennial logo
Home
  • About
    • Mission
    • Founder
    • Advisory Board
    • Partners & Funders
    • Research Independence
    • Contact
  • Careers
  • Resource Portal
  • Contact
  • People
    • Leadership
    • Faculty
    • Research Team
    • Operations Team
    • Education Team
    • Visiting Fellows
    • Margolis Scholars
    • Margolis Interns
    • Find an Expert
  • Research & Policy

    Focus Areas

    • Health Care Transformation
    • Biomedical Innovation
    • 21st Century Public Health
    • Education & Workforce Development

    Topics

    • Federal Health Care Transformation
    • State Health Care Transformation and Medicaid Transformation
    • Digital Health & AI
    • Coverage and Payment Policy
    More topics

    Publications

    • Case Studies
    • Journal Articles
    • Policy Briefs
    • Student Publications
    • White Papers
    • Op-Eds/Commentaries
    All publications

    Policy/Perspectives

    • Op-Eds/Commentaries
  • Education

    Focus Areas

    • Undergraduate Students
    • Graduate & Professional Students
    • Continuing Education

    Core Offerings

    • Undergraduate Health Policy Certificate
    • Duke-Margolis Postdoctoral & Affiliated Fellows Program
    • Health Policy Courses
    • Margolis Scholars Program
    • Margolis Internship Program
    • Summer Research Showcase
    • Bass Connections Health Policy and Innovation Theme
    • Career Resources and Opportunities
    • Health Equity Education

    Get Involved

    • Student Voices
    • Margolis Seminars
    • Point of Care Speaker Series
    • Stay Informed - Margolis Newsletter
    • Student Collaborative on Health Policy (SCOHP)
    • Duke Fuqua MBA Health Care Club (HCC)
  • News

    News

    • Duke-Margolis News
  • Events

    Events

    • COVID-19 Related Webinars
    • Margolis Seminars
    • Health Policy Talks
    • All Duke-Margolis Events
  • Give

Breadcrumb

  1. Home
  2. Publications
  3. Medicare Drug Price Negotiations: Policy Implications Of The First 10 Drugs' Features

Medicare Drug Price Negotiations: Policy Implications Of The First 10 Drugs' Features

Blog Entry

Medicare Drug Price Negotiations: Policy Implications Of The First 10 Drugs' Features

Published date

April 9, 2024

Topics

Coverage and Payment Policy, Drug Pricing and Competition Policy
View Publication

Authors

nitzan arad

Nitzan Arad, LLM

Area Lead for Drug Pricing and Competition Policy

Mark McClellan

Mark McClellan, MD, PhD

Director of the Duke-Margolis Institute for Health Policy
 Robert J. Margolis, MD, Professor of Business, Medicine and Policy
 Margolis Executive Core Faculty

  • People
  • Research
  • Education
  • News
  • Events
  • Give
  • About
  • Careers
  • Resource Portal
  • Contact Us

Contact

If you or your organization are interested in partnering with us, you can contact us.

Duke University logo

  • Connect

Duke University logo